Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The European Journal of Preventive Cardiology introduces 'PreventAble', a new section dedicated to sharing real-world implementation strategies for global cardiovascular disease prevention.
Preventive cardiology stands at a defining moment. Scientific progress has delivered robust evidence, practical guidelines, and innovative tools for preventing cardiovascular disease (CVD). Yet, despite this knowledge, CVD remains the leading cause of death globally. What limits progress today is not a lack of evidence but a failure to implement it effectively and equitably across the world. To address this gap, the European Journal of Preventive Cardiology (EJPC) proudly introduces a new section: PreventAble. This initiative aims to be more than a publication—it will serve as a catalyst for global collaboration, a source of shared experiences, and a forum to learn from real-world implementation of preventive cardiology. The name itself reflects our conviction: cardiovascular disease is prevent-able. The mission of PreventAble is to stimulate international collaboration in the lifelong implementation of cardiovascular prevention strategies.1 The vision is global: to learn from best practices across regions, cultures, and health systems. It seeks to highlight how prevention is being delivered—not in theory, but in practice—whether through legislative action, digital health innovation, community-based initiatives, or shifts in policy, health literacy, and clinical care. Articles will initially be invited to ensure thematic and geographic diversity, and will be concise with limited references. Each contribution will focus on lessons learned, barriers overcome, and creative approaches to implementation that can inspire action elsewhere. This section is designed to complement EJPC’s existing strengths in science and research by addressing the ‘how’ of prevention: How do we translate science and guidelines into care? How do we engage policymakers and patients? How do we adapt solutions to local challenges? Topics will include as follows: International case studies of effective preventive strategies. Policy and legislative efforts at national and regional levels. Technological innovation, such as digital apps, mobile health, and AI for risk prediction. Societal and environmental influences, including pollution, urban design, and socioeconomic inequality. Emerging health threats, such as the health impact of climate change or the rebranding of tobacco through vaping, and opportunities such as population-based cardiovascular screening, vaccinations, … This content will not only reflect clinical practice but also speak to public health, behavioural science, and systems-level change. PreventAble is underpinned by broad international support from across continents and specialties. Preventive cardiology is a global endeavour, and this section reflects that reality. It will draw on insights from clinicians, researchers, policymakers, and public health leaders from every region—North and South America, Europe, Asia, Africa, and Oceania. This diverse network will contribute a range of perspectives—highlighting the unique challenges faced by different populations, as well as the universal principles that unite us in the pursuit of better cardiovascular health. To shape the early identity of PreventAble, a series of carefully selected topics will be explored in the first volumes. These include as follows: Spotlights on pioneering centres: From cutting-edge digital prevention hubs to newly established national prevention organizations. Interviews with global health leaders, including voices from major health bodies such as WHO, WHF, and the European Commission. Policy and advocacy: How cardiovascular prevention can be embedded in broader health plans, and the role of cardiologists in influencing policy. Based on the successful ‘Prevention in your country’ developed by Prof. Joep Perk: A recurring feature highlighting national prevention plans, their development, and their outcomes. Behavioural and societal dimensions of prevention, including debates on alcohol, salt, and environmental pollutants. The role of technology, from AI-based risk scoring to persuasive app design, and mobile health strategies that bridge access gaps. Equity and inclusion, addressing how prevention can be made more inclusive in terms of gender, socioeconomic status, and digital literacy. We will also explore conceptual themes, such as the prevention paradox,2 the ethical dimensions of screening, and the complexities of adapting global guidelines to local realities. PreventAble is designed not just as a source of information, but as a platform for progress. Each issue will aim to: Encourage cross-sector dialogue between clinicians, policymakers, and researchers. Disseminate innovative models of care and policy through accessible and practical narratives. Highlight both success stories and cautionary tales to foster learning and adaptation. Engage wider audiences by promoting patient-centred summaries and media dissemination. Where appropriate, the section will align with major health observances and events—from World Heart Day to global sporting occasions—to raise the visibility of cardiovascular prevention. As PreventAble grows, the intention is to welcome submissions more broadly and to remain responsive to emerging trends. New formats may include interviews, expert debates, commentaries, or visual storytelling. The section may also be complemented by short videos, infographics, and summaries geared towards public education. Despite being preventable in large part, cardiovascular disease continues to exact a massive toll on individuals, families, and societies. The reasons are multifactorial—ranging from lifestyle to legislation, and from clinical inertia to systemic inequality. If we are to shift this trajectory, implementation science and practice must move to the centre of the conversation. That is what PreventAble aims to do: provide a space where implementation is celebrated, studied, and shared—across borders and disciplines. It will bring together perspectives that are too often siloed, highlighting not only what we know, but what we do—and how we can do it better. Prevention is not an aspiration—it is an obligation. Through PreventAble, we hope to foster a community of action, a space where prevention becomes tangible and transferable. We invite readers and contributors from around the world to be part of this journey. Share your stories. Bring your challenges. Celebrate your innovations. Let’s make cardiovascular prevention truly global, truly equitable, and truly achievable. Because together, we can make cardiovascular disease PreventAble. This effort is supported by a team of young clinicians: Ece Kizilkilic, Martijn Scherrenberg, Maarten Falter, Linqi Xu, Mauricio Milani, and Mayank Dalakoti. We hope you will enjoy this new feature
No takes yet. Share an insight, caveat, or question.
Dendale et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: